Sowell Financial Services LLC Sorrento Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$6.35 - $10.0 $40,405 - $63,630	-6,363 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$7.03 - $16.51 $20,773 - $48,787	2,955 Added 86.71%	6,363 $45,000
Q4 2020 Jan 13, 2021	BUY	$5.76 - $11.95 $4,389 - $9,105	762 Added 28.8%	3,408 $23,000
Q3 2020 Nov 12, 2020	BUY	$6.17 - $18.82 $3,060 - $9,334	496 Added 23.07%	2,646 $30,000
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $259 - $1,014	150 Added 7.5%	2,150 $14,000

Q4 2019 Feb 07, 2020	BUY	$1.45 - $4.17 $2,900 - $8,340	2,000 New	2,000 $6,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.